Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced-intensity allogeneic hematopoietic stem cell transplantation in chemosensitive relapsed follicular lymphoma
2009-013422-17Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Jul 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of rituximab in follicular lymphoma (FL), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: overall_survival_2y. Started Jul 2009; status: completed.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on 2009-013422-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013422-17.